Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Endocrine-Sensitive Disease Rate in Postmenopausal Patients with Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

Cynthia X. Ma,Vera J. Suman,Souzan Sanati,Kiran Vij,Meenakshi Anurag,A. Marilyn Leitch,Gary W. Unzeitig,Jeremy Hoog,Aranzazu Fernandez-Martinez,Cheng Fan,Richard A. Gibbs,Mark A. Watson,Travis J. Dockter,Olwen Hahn,Joseph M. Guenther,Abigail Caudle,Erika Crouch,Amy Tiersten,Monica Mita,Wajeeha Razaq,Tina J. Hieken,Yang Wang,Mothaffar F. Rimawi,Anna Weiss,Eric P. Winer,Kelly K. Hunt,Charles M. Perou,Matthew J. Ellis,Ann H. Partridge,Lisa A. Carey

JAMA ONCOLOGY（2024）

Cited 0|Views65
Key words
Neoadjuvant Therapy,Treatment Response
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined